Financhill
Back

Aclaris Therapeutics Stock Predictions

Aclaris Therapeutics Stock Forecast

  • Is Aclaris Therapeutics Stock Undervalued?
    The current Aclaris Therapeutics [ACRS] share price is $2.74. The Score for ACRS is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • ACRS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.

Will Aclaris Therapeutics Stock Go Up Next Year?

Data Unavailable

Aclaris Therapeutics Stock Rating

Data Unavailable

Aclaris Therapeutics Stock Price History

Is ACRS stock going to rise?

  • The current trend is moderately bearish and ACRS is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
aclaristx.com

52-Week Data

52-Week High:
5.17
52-Week Low:
0.86

Prediction Charts

Market Cap:
195.4M
Price in USD:
2.74
Volume:
1.2M
Beta:
0.60

Technical Analysis

SMA50:
2.67
SMA100:
1.93
SMA200:
1.57
52-Wk Change:
192.51%

Stock Predictions

  • Is Aclaris Therapeutics stock public?
    Yes, Aclaris Therapeutics is a publicly traded company.
  • What is the Aclaris Therapeutics stock quote today?
    The Aclaris Therapeutics stock price is 2.74 USD today.
  • How to buy Aclaris Therapeutics stock online?
    You can buy Aclaris Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-3 3.93 3.85 3.96 3.71
Dec-4 3.88 3.76 4.05 3.75
Dec-5 3.71 3.81 3.97 3.71
Dec-6 3.90 3.94 3.99 3.76
Dec-9 3.97 3.91 4.03 3.77
Dec-10 3.93 3.63 4.00 3.61
Dec-11 3.64 3.54 3.66 3.38
Dec-12 3.53 3.27 3.57 3.26
Dec-13 3.16 3.22 3.35 3.14
Dec-16 3.20 3.02 3.27 2.99
Dec-17 3.00 3.26 3.29 2.91
Dec-18 3.22 3.09 3.25 2.92
Dec-19 3.09 2.77 3.11 2.76
Dec-20 2.74 2.74 2.90 2.71

Aclaris Therapeutics Earnings

Data Unavailable

Aclaris Therapeutics Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.76 per share, and an increase next year of $0.38 per share.

* Aclaris Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.